Detection of β cell death in diabetes using differentially methylated circulating DNA

Area of Science:

• Endocrinology
• Molecular Biology
• Immunology

Background:

• Beta cell destruction in diabetes mellitus is often silent, leading to significant insulin secretion loss before detection.
• Current methods for assessing beta cell function and death are often invasive or indirect.

Purpose of the Study:

• To develop and validate a noninvasive method for detecting beta cell death in vivo.
• To quantify circulating beta cell-derived DNA as a biomarker for diabetes progression.

Main Methods:

• Developed a quantitative PCR assay using methylation-specific primers to detect beta cell-derived insulin DNA in serum.
• Applied the assay to serum samples from mice with induced diabetes and nonobese diabetic mice.
• Validated the assay in human serum and tissue samples from individuals with new-onset type 1 diabetes.

Main Results:

• Detected circulating beta cell-derived demethylated DNA in mouse serum.
• Observed increased levels of beta cell DNA after diabetes induction and during disease development in mice.
• Found elevated levels of demethylated insulin DNA in human subjects with new-onset type 1 diabetes compared to controls.

Conclusions:

• The developed assay provides a noninvasive method for detecting beta cell death in vivo.
• This biomarker can potentially track diabetes progression and inform treatment strategies.
• The findings offer a new tool for managing diabetes mellitus.